Pain Management

The results of a level 1 trauma center study have shown that ibuprofen injection (Caldolor, Cumberland Pharmaceuticals) significantly reduces the quantity of opioids required to manage pain after a traumatic injury with fracture.

The medication is indicated for the relief of mild to moderate pain caused by acute musculoskeletal disorders.

With medicinal cannabis research in its infancy, many health care providers are unsure how to provide accurate counseling and appropriate treatment to their patients.

Health care compliance analytics can be used to roll out institution-wide training and education programs to deter sloppy or nefarious behavior related to controlled substances.

The study concluded that pharmacists reportedly scored higher on the knowledge test than neurologists and nurse practitioners.

Low back pain is one of the leading reasons people seek medical care and the number 1 cause of disability globally.

Women are more likely to receive multiple opioid prescriptions, study finds.

Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.

The pharmaceutical industry is already seeing the immense benefit of AI and machine-learning technology.

Research shows that the over-prescribing of opioids for short term pain management is a widespread issue in the United States.

Which natural product or herbal medication could cause a severe phototoxic reaction to laser treatment?

Including medication disposal methods with prescriptions could reduce opioid diversion and childhood poisonings.

Sub-optimally managed pain is the outcome of a reactionary position to the opioid epidemic.

Migraines are a common condition, affecting about 38 million people in the United States and about 10% of people worldwide.

Why was a customer prescribed an allergy medication when she was expecting a pain pill?

Four case studies about skin and eye health.

Over-the-counter products featured in the May 2020 issue.

Amid differences in state programs, product labeling improvements must be adopted to protect patients.

In order to curb the opioid epidemic among employees, companies need to begin by identifying who is at risk.

Temptation exists because more than 90% of these patients are prescribed opioid medications for pain.

More than 53% of survey respondents reported having a diversion event within the last year, in addition to 37% who were aware of at least 1 colleague who has diverted controlled substances.

Researchers from the Mayo Clinic have found that inappropriate use of high-potency opioids has contributed to the opioid epidemic in the United States.

Why is this patient on oxybutynin if he does not have any problems with his bladder?

Cannabis products can counter some negative aspects of chemotherapy.

The FDA granted Amneal Pharmaceuticals for a generic version of buprenorphine (Butrans) transdermal system as well as a Competitive Generic Therapy designation.

Pain is the most common reason patients seek medical marijuana, yet patients' resulting consumption patterns of marijuana when treating pain may also have an effect on their health.

Research explores the impact of obesity on prescription opioid use, investigating specifically the link between obesity and long-term prescription use.

More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what physicians typically recommend for chronic pain relief via data from clinical studies, according to research published in PLOS ONE.

RedHill Biopharma Ltd today announced that it has completed the recently announced acquisition of the global rights to Movantik (naloxegol) for the treatment of opioid-induced constipation (OIC) from AstraZeneca.

A new study examining records from the Ohio Health Department from 2010 to 2017 found that white men between the ages of 30 and 39 had the highest risk for fatal opioid overdoses.